Retrospective review of in hospital use of mineralocorticoid receptor antagonists for high risk patients following myocardial infarction

BMC Cardiovascular Disorders

Volumn 15, Issue 1, 2015, Pages

  Miller, Robert J H ^a   Howlett, Jonathan G ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Heart failure; Mineralocorticoid receptor antagonists; Myocardial infarction

Indexed keywords

MINERALOCORTICOID ANTAGONIST;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; DIABETES MELLITUS; DRUG USE; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; CLINICAL PRACTICE; COMPLICATION; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HOSPITALIZATION; MIDDLE AGED; MYOCARDIAL INFARCTION; STATISTICAL MODEL; TRENDS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; DIABETES MELLITUS; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MINERALOCORTICOID RECEPTOR ANTAGONISTS; MYOCARDIAL INFARCTION; PRACTICE PATTERNS, PHYSICIANS'; RETROSPECTIVE STUDIES; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84935904682     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/s12872-015-0033-1     Document Type: Article

References (16)

1. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003;348:1309-21.
2. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med. 1999;341:709-17.
3. Masoudi FA, Gross CP, Wang Y, Rathore SS, Havranek EP, Foody JAM, et al. Adoption of spironolactone therapy for older patients with heart failure and left ventricular systolic dysfunction in the United States, 1998-2001. Circ. 2005;112:39-47.
4. Rassi AN, Cavender MA, Fonarow GC, Cannon CP, Hernandez AF, Peterson ED, et al. Temporal trends and predictors in the use of aldosterone antagonists post-acute myocardial infarction. J Am Coll Cardiol. 2013;61:35-40.
5. Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A, et al. Rates of hyperkalemia after publication of the randomized aldactone evaluation study. N Engl J Med. 2004;351:543-51.
6. Zannad F, McMurray JJV, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, et al. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med. 2011;364:11-21.
7. McKelvie RS, Moe GW, Cheung A, Costigan J, Ducharme A, Estrella-Holder E, et al. The 2011 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: focus on sleep apnea, renal dysfunction, mechanical circulatory support, and palliative care. Can J Cardiol. 2011;2011(27):319-38.
8. Arnold J, Ignaszewski A, Howlett J, LeBlanc MH, Liu P, Guiterrez R, et al. Changes in drug utilization in patients referred to outpatient heart failure clinics in Canada between 1999 and 2007. J Am Coll Cardiol. 2009;53:A166.
9. Canadian Institutes of for Health Information (CIHI). Canadian hospital reporting project. 2010.
10. Levey AS, Bosch JP, Lewis JB, Greene T. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999;130:461-70.
11. O'Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, de Lemos JA, et al. ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circ. 2013;2013(127):e362-425.
12. Lopez-de-Sa E, Martinez A, Anguita M, Dobarro D, Jimenez-Navarro M. Aldosterone receptor antagonist use after myocardial infarction. Data from the REICIAM registry. Rev Esp Cardiol. 2011;64:981-7.
13. Patel UD, Hernandez AF, Liang L, Peterson ED, LaBresh KA, Yancy CW, et al. Quality of care and outcomes among patients with heart failure and chronic kidney disease: a get with the guidelines-heart failure program study. Am Heart J. 2008;156:674-81.
14. Wang TY, Dai D, Hernandez AF, Bhatt DL, Heidenreich PA, Fonarow GC, et al. The importance of consistent, high-quality acute myocardial infarction and heart failure care results from the American Heart Association's Get with the Guidelines Program. J Am Coll Cardiol. 2011;58:637-44.
15. Fonarow GC, Albert NM, Curtis AB, Gheorghiade M, Heywood JT, Liu Y, et al. Associations between outpatient heart failure process-of-care measures and mortality clinical perspective. Circ. 2011;123:1601-10.
16. Sinuff T, Cook D, Giacomini M, Heyland D, Dodek P. Facilitating clinician adherence to guidelines in the intensive care unit: a multicenter, qualitative study. Crit Care Med. 2007;35:2083-9.